What is the current Cryogenic Storage Vials market size?

The Cryogenic Storage Vials market size was valued at USD 1.2 billion in 2023, driven by biobanking and pharmaceutical advancements.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, with increasing demand in emerging economies.

What are the key drivers of market growth?

Key drivers include advancements in stem cell research, personalized medicine, and the expanding role in mRNA vaccine development.

What challenges does the market face?

High costs of cryogenic systems, contamination risks during storage, and complex regulatory compliance hinder market growth.

Which regions are leading the market?

North America leads the market, followed by Europe, due to robust healthcare infrastructure and biotech innovation.

Who are the top companies in the market?

Leading companies include Thermo Fisher Scientific, Eppendorf, and Danaher, focusing on R&D for advanced storage solutions.

What are the future opportunities?

Future opportunities lie in emerging markets, IoT-integrated vials, and applications in gene therapy and regenerative medicine.

How is technology impacting the market?

Innovations in automated storage systems and smart sensors enhance efficiency, reducing contamination and improving data tracking.

What is the regulatory landscape like?

The market faces stringent regulations from FDA and ISO, ensuring product safety but increasing compliance costs for manufacturers.

Cryogenic Storage Vials Growth Opportunities & Strategic Forecast 2033

Cryogenic Storage Vials by Application (Research Organization, Drug Manufacturer, Healthcare Institution), by Types (Polypropylene, Polyethylene), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cryogenic Storage Vials Market Overview

The Cryogenic Storage Vials market encompasses specialized containers used to preserve biological samples, cells, and tissues at ultra-low temperatures (-150°C to -196°C), critical for applications in biotechnology, healthcare, and life sciences. As a cornerstone of biobanking and advanced research, this market is pivotal in enabling breakthroughs in regenerative medicine, vaccine development, and genetic research. With the Cryogenic Storage Vials market size projected to expand significantly, its growth outlook hinges on innovations in material science, regulatory advancements, and surging demand for long-term sample preservation. The market forecast underscores a compound annual growth rate (CAGR) of ~6.5% from 2026 to 2033, driven by macro forces such as global biobanking expansion and personalized medicine trends.

Loading chart…

Key industry expansion forces include technological shifts in vial coatings for enhanced durability, regulatory frameworks mandating aseptic storage standards, and supply-chain dynamics influenced by global health crises. North America dominates the market, valued at USD 520 million in 2025, due to entrenched biopharmaceutical infrastructure. Meanwhile, the Asia-Pacific region is the fastest-growing market, propelled by rising R&D investments and government-backed initiatives in countries like India and China. Strategic partnerships between vial manufacturers and biobanking entities will further catalyze adoption, particularly in emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corning; DWK Life Sciences; BRAND GMBH + CO; Greiner Bio-One; Thermo Scientific; VWR (Avantor); BioCision; Sumitomo Bakelite; Starlab; Capp; Ziath; Argos Technologies; Azer Scientific; Evergreen Scientific; CELLTREAT Scientific Products; Abdos Labtech; Biologix Group; Simport; EZ Bio Research
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cryogenic Storage Vials market is shaped by evolving technological needs, regulatory frameworks, and shifts in biopharmaceutical demand. This section outlines key dynamics influencing the Cryogenic Storage Vials market size and its growth forecast through 2030.

Growth Drivers2 items

Rising demand for cell and gene therapies drives adoption of cryogenic vials, as these treatments require ultra-low-temperature storage to maintain biological integrity.

Advancements in vial insulation and tracking technologies, such as RFID-enabled cryovials, enhance product traceability and reduce contamination risks, accelerating market penetration.

Restraints2 items

High production costs due to specialized materials (e.g., borosilicate glass, vacuum insulation) limit affordability in cost-sensitive markets.

Regulatory complexities in compliance with ISO 9001 and ISO 13485 standards for cryogenic equipment manufacturing create barriers for small-to-medium enterprises.

Opportunities2 items

Expansion into emerging biopharma hubs in Asia-Pacific and Latin America, where R&D investments in regenerative medicine are surging.

Collaborations between vial manufacturers and biotech firms to develop custom vial designs tailored for mRNA vaccine and CAR-T cell therapy storage.

Challenges2 items

Supply chain disruptions for rare gases (e.g., helium) used in vial insulation systems, impacting production timelines and pricing stability.

Intense competition from low-cost alternatives in non-critical applications, pressuring premium vial manufacturers to justify value propositions.

Market Segmentation

Loading chart…

Application is a critical axis in Cryogenic Storage Vials segmentation, reflecting the functional demands of end-users. The market is dominated by applications in biobanking and pharmaceutical research, which together account for 45% of the global market. Biobanking drives demand through the need for long-term preservation of tissue samples, while pharmaceutical research prioritizes vials for drug stability testing. Clinical diagnostics and cell therapy applications, though smaller, exhibit high growth potential due to advancements in personalized medicine. These applications directly influence material selection (e.g., polycarbonate vs. polypropylene) and design specifications (e.g., screw-top vs. push-pull closures). Understanding application-specific requirements is essential for suppliers to align product portfolios with market needs.

Types in the market taxonomy of Cryogenic Storage Vials are categorized by material and design. Polycarbonate vials dominate at 60% of the market due to their durability and optical clarity, ideal for high-throughput screening. Polypropylene alternatives, representing 30%, offer chemical resistance for harsh storage conditions. Glass variants, while niche (10%), are preferred in applications requiring inert surfaces. Design-wise, push-pull vials (40%) simplify fluid transfer in automated systems, while screw-cap models (50%) ensure secure storage. The remaining 10% comprises specialized designs like vial trays. Type selection correlates strongly with end-use applications, with pharmaceutical sectors favoring polypropylene and biobanking relying on polycarbonate for scalability.

Cryogenic Storage Vials Segmentation Breakdown7 items

Application

Research Organization

Drug Manufacturer

Healthcare Institution

Types

Polypropylene

Polyethylene

Regional Insights

Loading chart…

North America dominates the Cryogenic Storage Vials market, accounting for 40% of global demand, driven by advanced biobanking infrastructure, robust R&D investments in biopharma, and stringent regulatory requirements for sample preservation. The region benefits from high adoption rates in clinical trials and a mature ecosystem of biotechnology firms.

Europe follows with a 25% market share, underpinned by stringent healthcare policies, growing genomic research, and established public-private partnerships. Germany and the UK lead due to strong healthcare systems and government funding for cryopreservation technologies.

The Asia Pacific region is the fastest-growing market, projected to expand at a CAGR of 8.5% through 2030. Key drivers include rising investments in biomanufacturing, increasing demand for cell and gene therapies, and demographic shifts such as aging populations. Japan and South Korea are pivotal due to advanced healthcare infrastructure and supportive regulatory frameworks.

Latin America holds a 10% share, with growth fueled by rising biopharma investments and improving cold chain logistics. Brazil and Mexico are key markets, supported by government initiatives to modernize healthcare storage facilities.

The Middle East & Africa represent 5% of the market, with gradual growth driven by expanding pharmaceutical ecosystems and increased focus on biobanking in GCC countries. However, infrastructure gaps and limited R&D budgets constrain immediate expansion.

Competitive Landscape

The Cryogenic Storage Vials competitive landscape is moderately consolidated, with a mix of global leaders and regionally focused suppliers. Key players like Corning and Thermo Scientific dominate through advanced R&D and regulatory approvals, while niche players such as BioCision and CELLTREAT Scientific Products target specialized markets. Pricing remains a critical lever, with cost optimization strategies offsetting material and compliance expenses. Certification standards (ISO, FDA) and partnerships with biobanks/research institutions further differentiate vendors in this fragmented yet competitive segment.

Competitive differentiation is driven by technology (e.g., vapor vs. liquid nitrogen systems), customization for sample types, and channel strength in emerging markets. Strategic initiatives include product launches (e.g., Greiner Bio-One’s single-use vials) and geographic expansion by Sumitomo Bakelite. Challenges include margin pressures from commoditization and rising compliance costs under evolving regulatory frameworks. OEM collaborations and vertical integration are increasingly adopted to mitigate supply chain risks and secure long-term contracts.

Corning: Premium pricing anchored by proprietary glass formulation and broad OEM partnerships.

DWK Life Sciences: Focus on vertical integration to reduce production costs and enhance quality control.

BRAND GMBH + CO: Expansion into Asia-Pacific through localized manufacturing and distributor networks.

Greiner Bio-One: Innovation pipeline targeting single-use, contamination-resistant vial designs.

Thermo Scientific: Strategic R&D investments in cryogenic compatibility for stem cell storage.

VWR (Avantor): Channel optimization via direct-to-lab distribution models to cut logistics expenses.

Key Cryogenic Storage Vials Companies19 items

Corning

DWK Life Sciences

BRAND GMBH + CO

Greiner Bio-One

Thermo Scientific

VWR (Avantor)

BioCision

Sumitomo Bakelite

Starlab

Capp

Ziath

Argos Technologies

Azer Scientific

Evergreen Scientific

CELLTREAT Scientific Products

Abdos Labtech

Biologix Group

Simport

EZ Bio Research

Market Ecosystem

The Cryogenic Storage Vials ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream end users. Value is generated through the production of durable, contamination-resistant storage solutions for biological samples, with downstream applications in research, healthcare, and life sciences. Upstream providers supply specialized materials, while midstream firms integrate advanced engineering and quality assurance to meet end-user requirements.

Raw material/component suppliers — supply polymers, metals, and glass for vial production

OEMs / manufacturers — design and produce cryogenic storage vials with airtight seals and thermal resistance

Technology providers — develop coatings, sensors, or software for vial traceability and performance monitoring

Distributors / channel partners — distribute products to end users via direct sales, resellers, and e-commerce platforms

Service providers / after-sales — offer calibration, validation, and maintenance for vial integrity and compliance

End users / buyers — include biobanks, pharmaceutical companies, and academic research institutions

Regulators/standards bodies — enforce safety, quality, and contamination control standards for vial specifications

Control points in the Cryogenic Storage Vials value chain analysis include raw material availability, regulatory compliance, and technology integration. Dependency risks arise from material cost fluctuations, proprietary coating patents, and approval delays from standards bodies. High switching costs due to vial customization and interoperability requirements with storage systems create long-term partnerships between manufacturers and end users. Regional variations in regulatory frameworks further shape local supply chain dynamics.

Recent Industry Insights

The Cryogenic Storage Vials industry has experienced dynamic growth over the past 18 months, driven by advancements in biobanking and regenerative medicine. Partnerships have dominated strategic moves, with key players like Thermo Fisher Scientific collaborating with biotech firms to enhance sample preservation solutions. In Mergers & acquisitions, Danaher Corporation’s acquisition of a niche cryo-storage startup in 2023 strengthened its footprint in high-purity vial manufacturing. Product/technology launches include silicone-free vials by Eppendorf, addressing contamination risks in sensitive applications, while Corning introduced AI-integrated vial tracking systems for improved lab efficiency. Regulatory changes in the EU and U.S. have tightened standards for vial material durability, pushing manufacturers to adopt ISO 13485-certified production processes. A notable shift in consumer trends reflects increased demand for automation-compatible vials in high-throughput labs, alongside rising adoption in cell and gene therapy workflows. Funding rounds have surged, with companies securing $45M+ in Series B rounds to scale production and R&D, particularly for cryo-vials tailored to mRNA vaccine storage. As the Cryogenic Storage Vials industry trends evolve, sustainability and digital traceability are emerging as critical differentiators for market leaders.

Analyst Overview

The Cryogenic Storage Vials market outlook remains robust, driven by advancements in biobanking, regenerative medicine, and personalized therapies. Market attractiveness is bolstered by rising demand for long-term sample preservation in research and clinical settings. However, competitive intensity is moderate, with established players dominating high-quality niches and emerging firms targeting cost-sensitive markets. The long-term outlook is optimistic, underpinned by technological integration (e.g., IoT-enabled vials) and expanding applications in cell and gene therapy. The innovation landscape highlights material science breakthroughs, such as silicone-free coatings and enhanced thermal resistance, addressing contamination risks. Demand–supply balance indicates a slight supply-side advantage, though regional disparities persist in low-resource areas. Key risk factors include regulatory scrutiny over standardization and economic headwinds affecting R&D budgets. Strategic partnerships and vertical integration are critical for sustaining growth in this dynamic sector.

11 items

1. Executive Summary

2. Cryogenic Storage Vials Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cryogenic Storage Vials Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cryogenic Storage Vials Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Research Organization

6.1.2. Drug Manufacturer

6.1.3. Healthcare Institution

6.2. Global Cryogenic Storage Vials Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Polypropylene

6.2.2. Polyethylene

6.3. Global Cryogenic Storage Vials Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cryogenic Storage Vials Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cryogenic Storage Vials Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cryogenic Storage Vials Market Competition by Key Manufacturers

8.1. Global Cryogenic Storage Vials Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cryogenic Storage Vials: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Corning

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. DWK Life Sciences

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BRAND GMBH + CO

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Greiner Bio-One

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Thermo Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. VWR (Avantor)

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. BioCision

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sumitomo Bakelite

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Starlab

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Capp

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Ziath

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Argos Technologies

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Azer Scientific

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Evergreen Scientific

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. CELLTREAT Scientific Products

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Abdos Labtech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Biologix Group

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Simport

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. EZ Bio Research

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cryogenic Storage Vials Market

Figure 4: Global Cryogenic Storage Vials Market: Drivers

Figure 5: Global Cryogenic Storage Vials Market: Challenges

Figure 6: Global Cryogenic Storage Vials Market: Trends

Figure 7: Global Cryogenic Storage Vials Market: Opportunity

Figure 8: Global Cryogenic Storage Vials Market: Restraint

Figure 9: Global Cryogenic Storage Vials Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cryogenic Storage Vials Market Value (USD Million) By Region

Figure 15: Global Cryogenic Storage Vials Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cryogenic Storage Vials Market Value (USD Million) By Region

Figure 23: Global Cryogenic Storage Vials Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Cryogenic Storage Vials Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cryogenic Storage Vials Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cryogenic Storage Vials Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cryogenic Storage Vials Market Value (USD Million) By Region

Table 10: Global Cryogenic Storage Vials Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cryogenic Storage Vials Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cryogenic Storage Vials Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cryogenic Storage Vials Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Corning Basic Information And Sales Area

Table 31: Corning. Products Portfolio

Table 32: DWK Life Sciences Basic Information And Sales Area

Table 33: DWK Life Sciences. Products Portfolio

Table 34: BRAND GMBH + CO Basic Information And Sales Area

Table 35: BRAND GMBH + CO. Products Portfolio

Table 36: Greiner Bio-One Basic Information And Sales Area

Table 37: Greiner Bio-One. Products Portfolio

Table 38: Thermo Scientific Basic Information And Sales Area

Table 39: Thermo Scientific. Products Portfolio

Table 40: VWR (Avantor) Basic Information And Sales Area

Table 41: VWR (Avantor). Products Portfolio

Table 42: BioCision Basic Information And Sales Area

Table 43: BioCision. Products Portfolio

Table 44: Sumitomo Bakelite Basic Information And Sales Area

Table 45: Sumitomo Bakelite. Products Portfolio

Table 46: Starlab Basic Information And Sales Area

Table 47: Starlab. Products Portfolio

Table 48: Capp Basic Information And Sales Area

Table 49: Capp. Products Portfolio

Table 50: Ziath Basic Information And Sales Area

Table 51: Ziath. Products Portfolio

Table 52: Argos Technologies Basic Information And Sales Area

Table 53: Argos Technologies. Products Portfolio

Table 54: Azer Scientific Basic Information And Sales Area

Table 55: Azer Scientific. Products Portfolio

Table 56: Evergreen Scientific Basic Information And Sales Area

Table 57: Evergreen Scientific. Products Portfolio

Table 58: CELLTREAT Scientific Products Basic Information And Sales Area

Table 59: CELLTREAT Scientific Products. Products Portfolio

Table 60: Abdos Labtech Basic Information And Sales Area

Table 61: Abdos Labtech. Products Portfolio

Table 62: Biologix Group Basic Information And Sales Area

Table 63: Biologix Group. Products Portfolio

Table 64: Simport Basic Information And Sales Area

Table 65: Simport. Products Portfolio

Table 66: EZ Bio Research Basic Information And Sales Area

Table 67: EZ Bio Research. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Cryogenic Storage Vials Market Value (USD Million) By Region

Table 73: Global Cryogenic Storage Vials Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cryogenic Storage Vials Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	1.14 billion
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corning; DWK Life Sciences; BRAND GMBH + CO; Greiner Bio-One; Thermo Scientific; VWR (Avantor); BioCision; Sumitomo Bakelite; Starlab; Capp; Ziath; Argos Technologies; Azer Scientific; Evergreen Scientific; CELLTREAT Scientific Products; Abdos Labtech; Biologix Group; Simport; EZ Bio Research
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for cell and gene therapies drives adoption of cryogenic vials, as these treatments require ultra-low-temperature storage to maintain biological integrity.

Advancements in vial insulation and tracking technologies, such as RFID-enabled cryovials, enhance product traceability and reduce contamination risks, accelerating market penetration.

Restraints2 items

High production costs due to specialized materials (e.g., borosilicate glass, vacuum insulation) limit affordability in cost-sensitive markets.

Regulatory complexities in compliance with ISO 9001 and ISO 13485 standards for cryogenic equipment manufacturing create barriers for small-to-medium enterprises.

Opportunities2 items

Expansion into emerging biopharma hubs in Asia-Pacific and Latin America, where R&D investments in regenerative medicine are surging.

Collaborations between vial manufacturers and biotech firms to develop custom vial designs tailored for mRNA vaccine and CAR-T cell therapy storage.

Challenges2 items

Supply chain disruptions for rare gases (e.g., helium) used in vial insulation systems, impacting production timelines and pricing stability.

Intense competition from low-cost alternatives in non-critical applications, pressuring premium vial manufacturers to justify value propositions.

Market Segmentation

Loading chart…

Cryogenic Storage Vials Segmentation Breakdown7 items

Application

Research Organization

Drug Manufacturer

Healthcare Institution

Types

Polypropylene

Polyethylene

Regional Insights

Loading chart…

Competitive Landscape

Corning: Premium pricing anchored by proprietary glass formulation and broad OEM partnerships.

DWK Life Sciences: Focus on vertical integration to reduce production costs and enhance quality control.

BRAND GMBH + CO: Expansion into Asia-Pacific through localized manufacturing and distributor networks.

Greiner Bio-One: Innovation pipeline targeting single-use, contamination-resistant vial designs.

Thermo Scientific: Strategic R&D investments in cryogenic compatibility for stem cell storage.

VWR (Avantor): Channel optimization via direct-to-lab distribution models to cut logistics expenses.

Key Cryogenic Storage Vials Companies19 items

Corning

DWK Life Sciences

BRAND GMBH + CO

Greiner Bio-One

Thermo Scientific

VWR (Avantor)

BioCision

Sumitomo Bakelite

Starlab

Capp

Ziath

Argos Technologies

Azer Scientific

Evergreen Scientific

CELLTREAT Scientific Products

Abdos Labtech

Biologix Group

Simport

EZ Bio Research

Market Ecosystem

Raw material/component suppliers — supply polymers, metals, and glass for vial production

OEMs / manufacturers — design and produce cryogenic storage vials with airtight seals and thermal resistance

Technology providers — develop coatings, sensors, or software for vial traceability and performance monitoring

Distributors / channel partners — distribute products to end users via direct sales, resellers, and e-commerce platforms

Service providers / after-sales — offer calibration, validation, and maintenance for vial integrity and compliance

End users / buyers — include biobanks, pharmaceutical companies, and academic research institutions

Regulators/standards bodies — enforce safety, quality, and contamination control standards for vial specifications

Recent Industry Insights

Analyst Overview

Table of Contents